Work

Phase 1 Study Of The Novel Pan-Pim Kinase Inhibitor LGH447 In Patients With Relapsed/ Refractory Multiple Myeloma

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3186.3186

Authors: Marc S Raab, Enrique M. Ocio, Sheeba K. Thomas, Andreas Günther, Daniel Lebovic, Shaji K Kumar, Andrzej J. Jakubowiak, Dongweon Song, Fang Xiang, David Hynds, K. Gary Vanasse, Yeow Tee Goh

Institutions: Heidelberg University, University Hospital Heidelberg, Instituto de Investigación Biomédica de Salamanca, The University of Texas MD Anderson Cancer Center, Christian-Albrechts-Universität zu Kiel, University of Michigan, Mayo Clinic, University of Chicago Medical Center, Novartis (United States), Singapore General Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W170344355

FWCI: 2.135

Cites:

Cited by: 30

Related to: 10